- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Genomictree Inc (228760)
Genomictree Inc stock price live, this page displays KQ 228760 stock exchange data. View the 228760 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Genomictree Inc real time stock price chart below.
What Is the Genomictree Inc Stock Price Today?
The Genomictree Inc stock price today is 20,750.
What Is the Stock Symbol for Genomictree Inc?
The stock symbol for Genomictree Inc is ""228760.""
What Stock Exchange Does Genomictree Inc Trade On?
Genomictree Inc is listed and trades on the KOSDAQ stock exchange.
Is Genomictree Inc a Good Stock to Buy?
Determining whether Genomictree Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 228760 quote. (ISIN: KR7228760005)
What Is the Genomictree Inc Stock Price Today?
The Genomictree Inc stock price today is 20,750.
What Is the Stock Symbol for Genomictree Inc?
The stock symbol for Genomictree Inc is ""228760.""
What Stock Exchange Does Genomictree Inc Trade On?
Genomictree Inc is listed and trades on the KOSDAQ stock exchange.
Is Genomictree Inc a Good Stock to Buy?
Determining whether Genomictree Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 228760 quote. (ISIN: KR7228760005)
KOSDAQ
Currency in KRW
20,750
+550(+2.72%)
Closed·
Fair Value
An estimate of a Genomictree's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
19,510
20,900
52 wk Range
11,390
24,700
228760 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
228760 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Genomictree's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
19,51020,900
52 wk Range
11,39024,700
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
228760 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Genomictree's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell
Genomictree Inc Company Profile
Genomictree Inc., a biomarker-based molecular diagnostics company, develops and commercializes molecular diagnostic products for the detection of cancer and various infectious diseases. The company offers EarlyTect C, a screening method for early diagnosis of colorectal cancer; EarlyTect L for detection of epigenetic markers associated with lung cancer in pulmonary nodule patients; and EarlyTect B for detection of genetic and epigenetic markers associated with bladder cancer in hematuria patients. It also provides AccuraDTect SARS-CoV-2 RT-qPCR kits, test providers, and nucleic acid transport medium products. The company was founded in 2000 and is headquartered in Daejeon, South Korea.
Compare 228760 to Peers and Sector
Metrics to compare | 228760 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship228760PeersSector | |
|---|---|---|---|---|
P/E Ratio | −54.7x | −8.9x | −0.7x | |
PEG Ratio | −1.79 | −0.38 | 0.00 | |
Price/Book | 4.3x | 2.7x | 2.6x | |
Price / LTM Sales | 140.2x | 25.4x | 3.4x | |
Upside (Analyst Target) | - | 0.0% | 36.2% | |
Fair Value Upside | Unlock | 10.2% | 4.1% | Unlock |
Earnings
Latest Release
Aug 14, 2025
EPS / Forecast
-59.00 / --
Revenue / Forecast
1.72B / 8.00B
People Also Watch
FAQ
What Stock Exchange Does Genomictree Trade On?
Genomictree is listed and trades on the KOSDAQ stock exchange.
What Is the Stock Symbol for Genomictree?
The stock symbol for Genomictree is "228760."
What Is the Genomictree Market Cap?
As of today, Genomictree market cap is 498.35B.
What Is Genomictree's Earnings Per Share (TTM)?
The Genomictree EPS (TTM) is -379.45.
When Is the Next Genomictree Earnings Date?
Genomictree will release its next earnings report on 06 Nov 2025.
From a Technical Analysis Perspective, Is 228760 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Genomictree Stock Split?
Genomictree has split 2 times.
How Many Employees Does Genomictree Have?
Genomictree has 0 employees.
What is the current trading status of Genomictree (228760)?
As of 06 Oct 2025, Genomictree (228760) is trading at a price of 20,750, with a previous close of 20,200.00. The stock has fluctuated within a day range of 19,510 to 20,900, while its 52-week range spans from 11,390 to 24,700.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.